CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Clinical trial NCT03998163 · COMPLETED
Trial details
- NCT number
- NCT03998163
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-06
- Primary completion
- 2020-02-26
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.